Anxiety disorders are a significant problem in the community, and recent neuroimaging research has focused on determining the brain circuits that underlie them. Research on the neurocircuitry of anxiety disorders has its roots in the study of fear circuits in animal models and the study of brain responses to emotional stimuli in healthy humans. We review this research, as well as neuroimaging studies of anxiety disorders. In general, these studies have reported relatively heightened amygdala activation in response to disorder-relevant stimuli in post-traumatic stress disorder, social phobia, and specific phobia. Activation in the insular cortex appears to be heightened in many of the anxiety disorders. Unlike other anxiety disorders, post-traumatic stress disorder is associated with diminished responsivity in the rostral anterior cingulate cortex and adjacent ventral medial prefrontal cortex. Additional research will be needed to (1) clarify the exact role of each component of the fear circuitry in the anxiety disorders, (2) determine whether functional abnormalities identified in the anxiety disorders represent acquired signs of the disorders or vulnerability factors that increase the risk of developing them, (3) link the findings of functional neuroimaging studies with those of neurochemistry studies, and (4) use functional neuroimaging to predict treatment response and assess treatment-related changes in brain function.
INTRODUCTION
Anxiety disorders are marked by excessive fear (and avoidance), often in response to specific objects or situations and in the absence of true danger, and they are extremely common in the general population. According to a recent epidemiological study, the lifetime prevalence of any anxiety disorder is 28.8% (Kessler et al, 2005) . Anxiety disorders are associated with impaired workplace performance and hefty economic costs (Greenberg et al, 1999) , as well as an increased risk of cardiovascular morbidity and mortality (Albert et al, 2005; Kawachi et al, 1994; Smoller et al, 2007) . Given that anxiety disorders are a significant problem in the community, recent neuroimaging research has focused on determining the brain circuits that underlie them to inform the use of existing treatments and guide the possible development of new treatments. In the future, neuroimaging studies of anxiety disorders may also prove to be clinically helpful in the prediction of treatment response.
Given that excessive fear is a key component of anxiety disorders, it is not surprising that the search for the neurocircuitry of anxiety disorders has its roots in and has been closely intertwined with studies of fear circuits in animal models. A large volume of experimental work has examined the neurocircuitry associated with fear responses, mainly in rodents, using primarily fear conditioning, inhibitory avoidance, and fear-potentiated startle models. Key components of fear circuitry including the amygdala (and its subnuclei), nucleus accumbens (including bed nucleus of stria terminalis BNST), hippocampus, ventromedial hypothalamus, periaqueductal gray, a number of brain stem nuclei, thalamic nuclei, insular cortex, and some prefrontal regions (mainly infralimbic cortex) have been identified in these studies (for recent reviews see Davis, 2006; Maren, 2008; Quirk and Mueller, 2008) . These regions have their respective roles in the various components of fear processing such as the perception of threat or of unconditioned stimuli, the pairing of an unconditioned stimulus and conditioned response (learning/conditioning), the execution of efferent components of fear response, and the modulation of fear responses through potentiation, contextual modulation, or extinction. Some key findings from animal literature, such as the central role of amygdaloid nuclei in the acquisition of fear conditioning and expression of fear responses, the involvement of the hippocampus in contextual processing, and the importance of the infralimbic cortex in extinction recall, have been replicated across different studies and laboratories. These basic components of fear circuitry are well preserved across species and likely support similar functions in humans. Animal work using in vivo electrophysiological recording, tracing and lesions/reversible inactivation techniques was indispensable in acquiring this knowledge. Some recent work had even suggested that there might be separate fear and anxiety systems orchestrated through the central nucleus of the amygdala and the BNST, respectively (Davis, 2006) . These types of findings are particularly exciting as they might allow for a better focus on the neurocircuits involved in pathological anxiety.
On the other hand, other important issues, such as the exact neuroanatomical region that stores fear memory traces, or the exact role of a particular process (eg, the role of reconsolidation in fear memory, Nader and Hardt, 2009 ), or of a particular region (eg, the insular cortex) are intensely debated and actively studied. Nevertheless, the basic fear-related neurocircuitry identified in rodents is a useful place to start examining anxiety-related neurocircuitry in humans. It is important to note that the exact roles of many brain regions are yet to be firmly established and could differ across species. Even regions such as the amygdala, hippocampus, and nucleus accumbens might be involved in different, additional, or even unique tasks in humans (eg, the role of the hippocampus in explicit verbal memory in humans). Finally, there are major differences between human anxiety/anxiety disorders and fear conditioning models in animals. These differences include the frequent absence of clear unconditioned stimuli (US) in human anxiety disorders, and the central roles of avoidance and cognitive components (eg, anticipatory anxiety) in humans. These unique characteristics of anxiety disorders suggest potential involvement of other brain regions in addition to those identified in rodents, such as areas of prefrontal cortex that are more unique to humans. Thus, although animal studies are indispensable in understanding basic fear neurocircuitry, in vivo human studies are critical for understanding the neurocircuitry of anxiety disorders.
In this review, we will discuss three main topics: (1) fear neurocircuitry in healthy humans; (2) stress as a normal response to internal and external stimuli, and (3) anxiety disorders as defined in human psychopathology. The first of these topics will include a discussion of Pavlovian fear conditioning and extinction, pharmacologically induced fear and anxiety states, and the assessment of emotional stimuli in humans. In the third topic, we review the role of brain regions such as the amygdala, medial prefrontal cortex (including the rostral anterior cingulate cortex (rACC) and dorsal anterior cingulate cortex (dACC)), hippocampus, and insular cortex in anxiety disorders (Figure 1 ). Finally, we discuss some of the limitations of neuroimaging studies of anxiety disorders as well as the directions that we expect the field to take in the near future.
(For an outline of this review see the Appendix.)
FEAR NEUROCIRCUITRY IN HUMANS

Pavlovian Fear Conditioning and Extinction
Fear conditioning. In its most basic form, Pavlovian fear conditioning involves repeatedly presenting a previously neutral conditioned stimulus (CS; eg, a tone) with an aversive unconditioned stimulus (US; eg, a shock). After repeated pairings, the CS alone comes to elicit a conditioned fear response (eg, increased freezing, fear-potentiated startle, or skin conductance responses). Pavlovian fear conditioning has been used as a testable and translational, though admittedly simplistic, model of the acquisition of fears that might be relevant to some anxiety disorders like phobias and possibly to some aspects of post-traumatic stress disorder (PTSD).
Studies of Pavlovian fear conditioning in non-humans have highlighted the importance of the amygdala in the acquisition of fear conditioning (LeDoux, 2000; LeDoux et al, 1990; Pare et al, 2004; Sananes and Davis, 1992) . Similarly, functional neuroimaging studies in humans have reported amygdala activation during fear conditioning (Alvarez et al, 2008; Barrett and Armony, 2009; Buchel et al, 1998 Buchel et al, , 1999 Cheng et al, 2003 Cheng et al, , 2006 Gottfried and Dolan, 2004; Knight et al, 2004 Knight et al, , 2005 LaBar et al, 1998; Milad et al, 2007b; Morris and Dolan, 2004; Pine et al, 2001; Tabbert et al, 2006) , even when the CS is presented below perceptual thresholds (Critchley et al, 2002; 2009; Morris et al, 2001 ) and even when more complex USs are used (Doronbekov et al, 2005; Klucken et al, 2009 ). In addition, amygdala activity has been associated with skin conductance changes during fear conditioning (Cheng et al, 2006; Furmark et al, 1997; LaBar et al, 1998; Phelps et al, 2001) . Interestingly, amygdala activation in humans also has been observed in response to cues following (1) verbal instructions that discriminate between cues that predict shock vs safety (even though no shock was actually administered) , and (2) observational fear learning, whereby participants watch a video of another person experiencing a Pavlovian fear-conditioning paradigm (Olsson et al, 2007) . What exactly amygdaloid activation represents in these latter paradigms is not entirely clear. It could suggest for example that: (1) higher order centers that decipher the anticipated predictive value of the cue, or that learn from observation using empathy, convey information to the amygdala, or (2) alternatively, that the human amygdala is less specific in its responses and is more sensitive to contextual modulation in the absence of a US. These interpretations could have potentially different implications for the understanding of the role of the amygdala in anxiety disorders. Fear conditioning is also associated with increased activation in the dACC and rACC (Alvarez et al, 2008; Buchel et al, 1998 Buchel et al, , 1999 Dunsmoor et al, 2007; Klucken et al, 2009; LaBar et al, 1998; Marschner et al, 2008; Milad et al, 2007a, b; Morris and Dolan, 2004; Phelps et al, 2004) . Activation in the dACC and rACC also occurs during observational fear learning (Olsson et al, 2007) . In addition, dACC activation is positively correlated with differential skin conductance responses (Milad et al, 2007a) . Fear conditioning studies (involving both specific CSs and contexts) also commonly report insular cortex activation (Alvarez et al, 2008; Buchel et al, 1999; Buchel et al, 1998; Critchley et al, 2002; Dunsmoor et al, 2007; Gottfried and Dolan, 2004; Klucken et al, 2009; Knight et al, 2009; Marschner et al, 2008; Morris and Dolan, 2004; Phelps et al, 2001 Phelps et al, , 2004 and hippocampal activation (Alvarez et al, 2008; Buchel et al, 1999; Knight et al, 2004 Knight et al, , 2009 Lang et al, 2009; Marschner et al, 2008) .
Extinction. Extinction learning occurs when a CS that previously predicted a US no longer does so, and over time, the conditioned response (eg, freezing or elevated skin conductance responses) decreases. Extinction learning or, more likely, the later recall of this learning involves the ventromedial prefrontal cortex (vmPFC) (Milad and Quirk, 2002; Morgan et al, 1993; Quirk et al, 2000 Quirk et al, , 2003 Quirk et al, , 2006 in rodents. Functional neuroimaging studies of healthy humans have reported vmPFC activation during extinction (Barrett and Armony, 2009; Gottfried and Dolan, 2004; Kalisch et al, 2006; Milad et al, 2007b) and the later recall of extinction (Milad et al, 2007b; Phelps et al, 2004) . Skin conductance measures of extinction memory are positively correlated with vmPFC activation (Milad et al, 2007b; Phelps et al, 2004) and vmPFC cortical thickness (Milad et al, 2005) . Activation of the amygdala and insular cortex also may occur during extinction learning or recall (Gottfried and Dolan, 2004; LaBar et al, 1998; Milad et al, 2007b; Phelps et al, 2004) , and greater amygdala responses during extinction have been associated with higher trait anxiety (Barrett and Armony, 2009 ). Finally, extinction can be modulated by context (ie, the surroundings in which extinction takes place), and the hippocampus has a role in this process. In rodents, dorsal hippocampal lesions reduce the context-dependence of extinction (Bouton et al, 2006) . In a recent fMRI study, hippocampal activation to the CS + occurred in the extinction context but not in the conditioning context (Kalisch et al, 2006) . Hippocampal activation was also positively correlated with vmPFC activation in this study (Kalisch et al, 2006) , suggesting that hippocampal-vmPFC interactions may be important for the contextual modulation of extinction.
Fear States and Responses to Emotional Stimuli
Pharmacological challenge. Another way to examine the mediating functional neuroanatomy of fear or anxiety is to use specific pharmacological agents to provoke such states in healthy individuals during PET or fMRI scanning. For example, cholecystokinin-4 (CCK-4) is associated with increases in subjective states of fear and anxiety, as well as increased activation in the amygdala, insular cortex, claustrum, cerebellum, brain stem, and the ACC (Benkelfat et al, 1995; Eser et al, 2009; Javanmard et al, 1999; Schunck et al, 2006) . In addition, two studies reported dACC increases during anticipatory anxiety preceding the CCK administration (Eser et al, 2009; Javanmard et al, 1999) . It is important to keep in mind, however, that CCK-B receptor agonists like pentagastrin also have direct effects on stress axis stimulation independent of their effects on subjective experience of distress/fear (Abelson et al, , 2008 . Procaine administration has been associated with elevated subjective ratings of fear/anxiety, activation of the amygdala, ACC, and insular cortex (Ketter et al, 1996; Servan-Schreiber et al, 1998) , and deactivation of neocortical structures (Servan-Schreiber et al, 1998) . Furthermore, amygdala activity was positively correlated with subjective reports of anxiety (Ketter et al, 1996; Servan-Schreiber et al, 1998) . Interestingly, those subjects who did not have a panic attack in response to procaine had greater activation in the rACC compared with those who did have a panic attack (Servan-Schreiber et al, 1998) , consistent with the idea that the rACC may perform a regulatory or inhibitory function (Mayberg, 1997) . The alpha-2 adrenergic antagonist yohimbine has likewise been associated with increased normalized blood flow in medial prefrontal cortex, insular cortex, and cerebellum in healthy individuals (Cameron et al, 2000) . A major caveat in the interpretation of pharmacological challenge studies, however, is the difficulty in disentangling the effects that are specific to fear induction from the direct effect of a pharmacological agent on regional brain activity and from the non-specific effects of the pharmacological agent.
Emotional stimuli. Over the past two decades, functional neuroimaging studies have shown that a core set of brain regions mediate responses to emotional stimuli in healthy humans. (For reviews, see Phan et al, 2002; Phan et al, 2004b) . The relevance of these studies to fear/anxiety circuitry is two-fold: (1) A significant number of these emotional activation paradigms utilize stimuli that depict and/or elicit fear, and (2) these studies shed light on more general emotion-generating neurocircuitry. PET and fMRI studies have reported amygdala activation in response to emotionally negative photographs (Britton et al, 2006; Hariri et al, 2002; Irwin et al, 1996; Lane et al, 1997a; Paradiso et al, 1999; Phan et al, 2003b; Reiman et al, 1997; Taylor et al, 1998) , odors (Zald and Pardo, 1997) and tastes (Zald et al, 1998) . Several studies have reported amygdala activation to positive stimuli as well (Garavan et al, 2001; Hamann and Mao, 2002; Hamann et al, 1999 Liberzon et al, 2003) , which suggests that the amygdala responds more broadly to emotionally arousing and/or salient stimuli (Phan et al, 2004b) . Reappraisal of emotionally negative photographs is associated with reduced amygdala activation (Ochsner et al, 2002) and increased ventromedial prefrontal cortex activation (Urry et al, 2006) . Finally, amygdala activation during encoding of emotionally arousing stimuli is correlated with the subsequent recollection of those stimuli (Cahill et al, 1996; Dolcos et al, 2004 Dolcos et al, , 2005 Hamann et al, 1999) .
Medial prefrontal cortex, including the rACC, also activates in response to emotional pictures (Lane et al, 1997a, b; Phan et al, 2003a Phan et al, , b, 2004a Reiman et al, 1997) and may mediate self-referential processing (Kelley et al, 2002; Lane et al, 1997a; Zysset et al, 2002) . Although the medial prefrontal cortex may activate regardless of task or valence, the rACC may be more likely to activate when a cognitive task is performed during scanning (Phan et al, 2002) . Ventromedial PFC responses to fear-related images have been negatively associated with cortisol reactivity (Root et al, 2009) . The dACC also activates in response to emotional photographs (Britton et al, 2006; Teasdale et al, 1999) and aversive tastes (Zald et al, 1998) . Finally, the insular cortex is responsive to aversive stimuli (Phan et al, 2004a) , internally generated sadness (Lane et al, 1997b; Reiman et al, 1997) and disgust-related stimuli (Britton et al, 2006) .
Emotional facial expressions. Interestingly, the same neurocircuitry that has been implicated in fear/anxiety responses in humans is readily activated by stimuli that are not intrinsically threatening, but may convey information regarding the presence of threat in the environment or about the fearful emotional state of others. Responses in the amygdala are readily elicited by photographs of facial expressions, especially those of fear (Breiter et al, 1996a; Davis and Whalen, 2001; Fitzgerald et al, 2006; Morris et al, 1996; Vuilleumier and Pourtois, 2007; Whalen et al, 2001) , even when presented below conscious awareness Whalen et al, 1998 Whalen et al, , 2004 . Emotional facial expressions have also been associated with activation in the dACC, rACC, medial frontal gyrus, and insular cortex (Fitzgerald et al, 2006; Gorno-Tempini et al, 2001; Morris et al, 1996; Phillips et al, 1997 Phillips et al, , 2004 Sabatini et al, 2009; Sprengelmeyer et al, 1998) .
Brain responses to the relatively ambiguous facial expression of surprise have been shown, in some studies, to depend on the extent to which individual subjects interpreted these expressions as positive or negative; more negative interpretations were associated with greater amygdala and lower ventral medial prefrontal cortex activation (Kim et al, 2003) . These findings are consistent with the notion that the amygdala and medial prefrontal cortex are reciprocally modulated (eg, Garcia et al, 1999) . Furthermore, the experimental manipulation of the context in which surprise facial expressions are presented alters brain activation patterns in a similar way: surprise expressions associated with a negative context elicited more amygdala activation than those associated with a positive context . These amygdala activations were positively correlated with activation in the dACC .
Of relevance to our later discussion of anxiety disorders are findings that suggest that healthy individuals with high scores on anxiety measures have greater amygdala and insular cortex responses to emotional (angry, fearful, and happy) faces and less rACC activation than participants with normative scores on these measures (Bishop et al, 2004a, b; Stein et al, 2007) . Similarly, trait anxiety has been positively correlated with amygdala responses to neutral faces .
Summary
Studies of fear conditioning, pharmacologically induced fear, and responses to emotional stimuli and facial expressions have provided evidence that the human amygdala, although responsive to multiple salient stimuli, responds reliably and potentially preferably to stimuli that predict threat and can be involved in mediating fear/anxiety states. Given that patients with anxiety disorders experience fear and distress in response to possible predictors of threat, the amygdala has been hypothesized to be hyperresponsive in some anxiety disorders. In the next section, we will review the evidence related to this hypothesis.
Studies of extinction have highlighted the potential involvement of the vmPFC and hippocampus in the process of learning and remembering that stimuli that used to predict threat no longer do. One possible reason for exaggerated fear, anxiety, and distress in patients with anxiety disorders is that these emotional responses fail to extinguish or that extinction learning is not recalled even when specific cues no longer predict threat. Indeed, some studies have reported impaired extinction in several anxiety disorders, such as PTSD (Blechert et al, 2007; Milad et al, 2008; Orr et al, 2000; Peri et al, 2000; Wessa and Flor, 2007) . Thus, the vmPFC and hippocampus are clear regions of interest in functional neuroimaging studies of anxiety disorders.
Finally, both the animal literature and studies reviewed above suggest that the dACC (and its likely homolog prelimbic cortex) and insular cortex respond to emotional stimuli or those that predict threat. As with the amygdala, hippocampus, and vmPFC, these regions are involved in multiple other functions; however, they might also have important roles in specific aspects of anxiety. For example, the insular cortex is thought to mediate the monitoring of internal body states, and has been found to be hyperresponsive in anxiety-prone individuals . In summary, research on healthy individuals has suggested that all of these brain regions are prime candidates to examine in patients with anxiety disorders.
STRESS
An important and often overlooked aspect of the fear/ anxiety neurocircuitry is its overlap and interaction with the neurocircuitry that orchestrates the stress response. It is important to note that the concept of 'stress' used here is relatively specific. It does not encompass general concepts of 'subjective distress' or 'performance load.' Although these are useful concepts, they are heterogeneous by nature and are not likely to be associated with a specific neurocircuitry. On the other hand, the concept of a stress system that leads to activation of limbic-hypothalamopituitary-adrenal axis (LHPA) and secretion of stress hormones like corticotropin-releasing hormone (CRH), adrenocorticotropic hormone, and cortisol is quite specific and is likely to be highly relevant to the neurocircuitry of fear and anxiety. The neurocircuitry governing LHPA activation has been the focus of intense studies in rodents, primates, and humans because it has been repeatedly linked to the neurobiology of mood disorders (which is addressed in detail elsewhere in this volume), but the evidence linking LHPA axis abnormalities to anxiety disorders has been less consistent, sometimes confusing, and often oversimplified. At the same time, some of the same brain regions are implicated in both anxiety and stress responses, suggesting that these responses are interrelated and can influence each other. Furthermore, anxiety and mood disorders are highly comorbid, suggesting that some common abnormalities in neurocircuitry might be present in both disorders. In the following few paragraphs, we briefly address only the structural overlap in neurocircuits and the effects of stress system activation (or stress hormones) on anxiety/fear neurocircuitry.
Epidemiologically, major depression is highly comorbid with anxiety disorders like PTSD, panic disorder, and social phobia (Reiger et al, 1990) , and anxiety symptoms are highly prevalent in depression (Frances et al, 1990) . Furthermore, major subcortical components of the LHPA axis (eg, hypothalamus, hippocampus, amygdala, and BNST) have also been identified as key components of anxiety/fear neurocircuitry (albeit sometimes involving different subnuclei, for example paraventricular nuclei vs ventromedial hypothalamus for LHPA and fear neurocircuitry, respectively). More recently with the introduction of in vivo imaging methodologies in LHPA/stress research, the role of cortical structures like the insula and dorsal mPFC in the activation and inhibition of stress response, respectively, has been reported (Liberzon and Martis, 2006) as well as the role of subgenual ACC in self-induced sadness and depression (Mayberg et al, 1999) . Together, these findings suggest a significant overlap in structures involved in the stress response and those involved in fear/anxiety responses (eg medial prefrontal cortex, insula, amygdala, hippocampus, and BNST). Finally, with respect to neurotransmitters involved, CRH is likely involved in the orchestration of both LHPA axis activity and many anxiety/fear responses. (For a review see Heim and Nemeroff, 2001 .)
The activation of these overlapping regions in functional neuroimaging studies does not necessarily signify, however, activation of both the fear/anxiety response and the LHPA axis. As a matter of fact, activation of fear/anxiety does not necessarily activate an LHPA stress response, even in highly fearful (phobic) individuals (Curtis et al, 1976) . In turn, activation of LHPA axis is not necessarily experienced subjectively as fear or anxiety. For example, morning awakening, food intake, and nausea all lead to LHPA axis activation without notable increases in subjective sense of fear. It is becoming increasingly clear that specific characteristics of experience (novelty, control, social support, etc.) are more salient for LHPA axis activation than degree of subjective distress or fear (Abelson et al, 2007) . These facts help to better understand the findings of non-specific, or even sometimes counterintuitive, findings regarding the LHPA and stress responses in anxiety disorders such as panic disorder (Abelson et al, 2007) and PTSD (Yehuda, 2006; Yehuda et al, 1991) . This also suggests that activation in specific cortical regions like mPFC or insula cannot be readily interpreted as a component of the fear response, and has to be considered within a context of a specific experiment, subjective report, symptoms, neuroendocrine profile, etc.
With these caveats in mind, important findings about stress exposure and LHPA axis activation affecting fear/ anxiety responses have been accumulating. These can be seen in two general categories: (1) the immediate effects of stress or of stress hormones on fear/anxiety responses (eg, stress or stress hormone exposure immediately precedes, or is present during the fear/anxiety responses), and (2) delayed or developmental effects, (eg, stress exposure during developmentally sensitive periods, like early childhood, modulates fear/anxiety responses later in life). In the former category, it has been reported that exposure to acute stress in healthy individuals potentiates the anxiety response (Grillon et al, 2007) . In addition, stress exposure (Trier Social Stress Test) led to enhanced galvanic skin responses to conditioned stimuli (CS + ) during fear conditioning . Interestingly, stress modulates fear responses differentially in men and women. Differential effects of stress on fear/anxiety in females vs males also have been demonstrated in animal studies.
Chronic stress exposure led to impaired extinction recall of fear conditioning in male but not female rats (Baran et al, 2009 ). Stress exposure in animal studies also led to enhancement in contextual fear conditioning (Cordero et al, 2003) . The effects of stress hormone exposure are somewhat more difficult to interpret because higher endogenous cortisol levels were associated with higher skin conductance responses (SCR) , whereas administration of exogenous cortisol led to decreased SCR .
With respect to delayed effects of stress during the vulnerable developmental period, the findings are somewhat complex. Studies of early maternal separation in rodents (Plotsky and Meaney, 1993) and variable foraging in primates (Coplan et al, 1996) have revealed long-term alteration in stress axis responses and key neurotransmitter systems (for review see Heim and Nemeroff, 2001 ). In addition, recent findings of gene-by-environment interactions in PTSD (Binder et al, 2008 ) also point toward the possibility that early childhood experience might modify fear/anxiety neurocircuitry and contribute to the development of anxiety disorders. Direct evidence of these effects on fear/anxiety behavior is less convincing, however, as maternal separation in rat pups, which did alter relevant neurotransmitter systems, did not result in significantly enhanced startle response or decreased open field exploration as compared with non-separated animals (Caldji et al, 2000) . Similarly, mixed results have been obtained in other studies where rats exposed to severe sporadic stress spent more time in open arms of an elevated plus maze but displayed increases in defensive probe burying behavior. Furthermore, animals exposed to milder chronic stress showed opposite changes (Pohl et al, 2007) .
The character of the stress exposure (mild vs severe, prolonged vs short, predictable vs non-predictable) and the sex of the individual emerge as important variables that can define the long-term effects of stress exposure, but more experimental data are clearly needed. Similarly, little is known about the specific mechanisms by which stress exposure modulates fear/anxiety circuitry. It has been suggested, as stated above, that early developmental stress exposure alters fear/anxiety circuitry via altered sensitivity and responsivity of the CRH and adrenergic systems, and recent advances in morphological work had suggested a potential mechanism for the effects of stress on fear conditioning and extinction. Chronic stress decreases dendritic branching in the hippocampus (McEwen, 2001) and mPFC (Liston et al, 2006; Radley et al, 2004) , but increases dendritic branching in the amygdala (Mitra et al, 2005; Vyas et al, 2006) . This pattern could lead to increased conditioning and impaired extinction, and both of these processes could contribute changes in anxiety/fear-related behaviors. Future research addressing these important questions will be needed to fully understand the impact of stress/LHPA axis activation on fear/anxiety and the underlying neurocircuitry.
ANXIETY DISORDERS
Posttraumatic Stress Disorder
PTSD can develop in individuals who (1) were exposed to an event or events that involved the threat of death or serious injury and (2) reacted with intense fear, helplessness or horror (APA, 2000) . Individuals with PTSD reexperience the traumatic event in the form of nightmares, intrusive recollections, flashbacks, and physiological arousal and distress in response to reminders of trauma. These patients may attempt to avoid reminders of the trauma and may experience a restricted range of effect, especially positive effect. Finally, patients with PTSD report hyperarousal symptoms, such as hypervigilance, exaggerated startle, and difficulty sleeping or concentrating (APA, 2000) .
Neurocircuitry models of PTSD implicate the amygdala, mPFC, and hippocampus (Rauch et al, 1998b (Rauch et al, , 2006 . According to some models, the amygdala is hyperresponsive in PTSD, which may account for exaggerated fear responses and the persistence of traumatic memories. In addition, portions of the vmPFC (including the rACC) are hyporesponsive and fail to inhibit the amygdala. It is not clear which of the two regions 'drives' the overall outcome, but a hyperresponsive amygdala and hyporesponsive mPFC may potentially lead to deficits in extinction, emotion regulation, attention, and contextual processing (Liberzon and Sripada, 2008) . Abnormal hippocampal function may contribute to deficits in contextual processing, as well as impairments in memory and neuroendocrine dysregulation. Although not originally included in early neurocircuitry models, the dACC and insular cortex may have a role in PTSD as well. Recent studies have suggested that the dACC is hyperresponsive in PTSD, perhaps underlying exaggerated fear learning. Finally, the insular cortex appears to be hyperresponsive in PTSD and other anxiety disorders, consistent with the notion that the insula may mediate anxiety proneness Simmons et al, 2006) . (For other models, see Elzinga and Bremner, 2002; Hamner et al, 1999; Layton and Krikorian, 2002.) Amygdala. Several studies have reported increased amygdala activation in PTSD relative to comparison groups in response to trauma-related imagery (Shin et al, 1997; Shin et al, 2004a) , combat-related sounds or smells (Liberzon et al, 1999; Pissiota et al, 2002; Vermetten et al, 2007) , trauma-related photographs or words (Driessen et al, 2004; Hendler et al, 2003; Morey et al, 2009; Protopopescu et al, 2005) , fear conditioning , and fearful facial expressions (Bryant et al, 2008b; Rauch et al, 2000; Shin et al, 2005; Williams et al, 2006) . Exaggerated amygdala activation in PTSD has also been found at rest (Chung et al, 2006; Semple et al, 2000) and during the completion of neutral attention and memory tasks (Bryant et al, 2005; Shin et al, 2004b) . Several studies, however, have found no differential response in the amygdala in PTSD (eg, Bremner et al, 1999a; Lanius et al, 2001) or even decreased responsivity to negative stimuli (Phan et al, 2006a) . Interestingly, resilience to PTSD may be associated with relatively decreased amygdala activation (Britton et al, 2005; Osuch et al, 2008) , and amygdala lesions may reduce the occurrence of PTSD (Koenigs et al, 2008) . In support of the potential role of amygdala in PTSD, some studies have reported that amygdala activation is positively correlated with PTSD symptom severity Dickie et al, 2008; Pissiota et al, 2002; Protopopescu et al, 2005; Rauch et al, 2000; Shin et al, 2004a) . Similarly, response to cognitive-behavioral treatment is associated with a decrease in amygdala activation Peres et al, 2007) , and relatively higher pre-treatment amygdala activation is predictive of a less favorable response to cognitivebehavioral therapy (Bryant et al, 2008a) .
Relatively few studies have examined amygdala structure and neurochemistry in PTSD. Two studies have reported trends for smaller amygdala volumes in PTSD (Bremner et al, 1997; Wignall et al, 2004) , but several others have not (Bonne et al, 2001; De Bellis et al, 2001a; FennemaNotestine et al, 2002; Gilbertson et al, 2002; Gurvits et al, 1996; Lindauer et al, 2004b) . One recent study using PET and 11 C-carfentanil has reported diminished mu-opioid receptor binding in the extended amygdala in traumaexposed individuals with vs without PTSD (Liberzon et al, 2007b) . Another study has found decreased [ 11 C]flumazenil binding in the left amygdala in PTSD subjects compared with trauma-exposed control participants, consistent with altered GABAergic function in this disorder (Geuze et al, 2008a) , although two other studies have not reported this finding (Bremner et al, 2000a; Fujita et al, 2004) .
Medial prefrontal cortex. Functional neuroimaging studies of PTSD have reported decreased activation or failure to activate the mPFC (including the rACC, medial frontal gyrus, and subcallosal cortex) during traumatic scriptdriven imagery (Bremner et al, 1999a; Britton et al, 2005; Lanius et al, 2001; Lindauer et al, 2004a; Shin et al, 1999 Shin et al, , 2004a , the presentation of trauma-related stimuli (Bremner et al, 1999b; Hou et al, 2007; Yang et al, 2004) , and negative, non-traumatic stimuli (Kim et al, 2007; Lanius et al, 2003; Phan et al, 2006a; Shin et al, 2005; Williams et al, 2006) . Relatively diminished activation of the mPFC in PTSD also has been shown during extinction , emotional Stroop interference (Bremner et al, 2004; Shin et al, 2001) , emotional word retrieval (Bremner et al, 2003b) , non-emotional cognitive tasks (Bryant et al, 2005; Semple et al, 2000) and at rest (Semple et al, 2000) . Furthermore, mPFC activation appears to be inversely correlated with PTSD symptom severity (Britton et al, 2005; Dickie et al, 2008; Hopper et al, 2007; Kim et al, 2007; Shin et al, 2004a Shin et al, , 2005 Williams et al, 2006) and positively correlated with pre-scan cortisol levels (Liberzon et al, 2007a) . Finally, increased mPFC activation following treatment has been positively associated with symptomatic improvement Lansing et al, 2005; Peres et al, 2007; Seedat et al, 2004) , although not all studies have shown this, perhaps due to paradigm-related methodological differences (Bryant et al, 2008a) .
Most of the findings summarized above reflect activation peaks in rostral ACC and ventral portions of the mPFC. In contrast, more dorsal regions of the ACC (ie, the dACC) appear to have either normal or exaggerated responsivity in PTSD during fear conditioning, interference tasks, an auditory oddball task, and at rest Bryant et al, 2005; Felmingham et al, 2009; Pannu Hayes et al, 2009; Shin et al, 2001 Shin et al, , 2007 ).
The findings of several studies suggest diminished volumes or gray matter densities in the ACC in PTSD Kasai et al, 2008; Rauch et al, 2003; Woodward et al, 2006; Yamasue et al, 2003) , and smaller ACC volumes have been associated with greater PTSD symptom severity (Woodward et al, 2006; Yamasue et al, 2003) . In a study of monozygotic twins discordant for trauma exposure, diminished gray matter densities in pregenual ACC were not found in the identical twins of the PTSD participants, suggesting that this gray matter density decrease is likely an acquired sign of the disorder rather than a familial risk factor (Kasai et al, 2008) .
Magnetic resonance spectroscopy (MRS) studies have revealed diminished N-acetyl aspartate (NAA) levels in the ACC in PTSD (De Bellis et al, 2001b, b; Ham et al, 2007a; Mahmutyazicioglu et al, 2005; Schuff et al, 2008) . Furthermore, NAA levels in the pregenual ACC were negatively correlated with the severity of reexperiencing symptoms (Ham et al, 2007a) . Two recent studies have reported decreased benzodiazepine receptor binding in the mPFC in PTSD (Bremner et al, 2000a; Geuze et al, 2008a) , although one other study failed to find this effect (Fujita et al, 2004) .
Hippocampus. Some functional neuroimaging studies have reported decreased hippocampal activation during symptomatic states (Bremner et al, 1999a) and during memory tasks that involve neutral or emotional stimuli (Astur et al, 2006; Bremner et al, 2003a, b; Moores et al, 2008; Shin et al, 2004b) . One study found reduced glucose metabolic rate in the hippocampus at rest (Molina et al, 2007) , and another reported that successful treatment was related to increased hippocampal activation (Peres et al, 2007) . Other studies, however, have reported increased activation in the hippocampus in PTSD (Geuze et al, 2007 (Geuze et al, , 2008b Sachinvala et al, 2000; Semple et al, 2000; Thomaes et al, 2009; Werner et al, 2009) or a positive correlation between hippocampal activation and PTSD symptom severity (Osuch et al, 2001; Shin et al, 2004b) . The direction of hippocampal functional abnormalities appears to depend in part on the type of task and the type of statistical analysis used.
Hippocampal volumes appear to be diminished in PTSD in some (Bossini et al, 2008; Bremner et al, 1995 Bremner et al, , 1997 Bremner et al, , 2003a Gilbertson et al, 2002; Gurvits et al, 1996; Karl et al, 2006; Kitayama et al, 2005; Smith, 2005; Stein et al, 1997; Villarreal et al, 2002a; Wignall et al, 2004; Winter and Irle, 2004; Woon and Hedges, 2008) , but not all studies (Bonne et al, 2001; Carrion et al, 2001; De Bellis et al, 1999 , 2002 Fennema-Notestine et al, 2002; Golier et al, 2005; Pederson et al, 2004) . Hippocampal volumes have been inversely associated with verbal memory deficits (Bremner et al, 1995) , combat exposure severity (Gurvits et al, 1996) , dissociative symptom severity (Bremner et al, 2003a; Stein et al, 1997) , depression severity (Villarreal et al, 2002a) , and PTSD symptom severity (Bremner et al, 2003a; Gilbertson et al, 2002; Villarreal et al, 2002a) . Spectroscopy studies of hippocampus have reported decreased NAA in the hippocampus, often interpreted as consistent with decreased neuronal integrity (Brown et al, 2003; Freeman et al, 1998; Ham et al, 2007a; Mohanakrishnan Menon et al, 2003; Schuff et al, 2001; Villarreal et al, 2002b) . The results of two studies suggest that hippocampal volumes may increase following treatment with serotonin reuptake inhibitors (Bossini et al, 2007; Vermetten et al, 2003) .
Whether decreased volumes can explain abnormal hippocampal activation in PTSD is not entirely clear, although the findings of at least two studies suggest that functional abnormalities might be still present even if the volumetric differences are controlled statistically (Bremner et al, 2003a; Shin et al, 2004b) . The origin of decreased hippocampal volumes is not known, although the results of one twin study suggest that diminished hippocampal volumes may be a familial risk factor for developing PTSD following psychological trauma (Gilbertson et al, 2002) .
With regard to neurochemistry, one recent PET study found decreased [ Insular cortex. Relative to comparison groups, increased activation in the insular cortex has been found in PTSD during script-driven imagery Lindauer et al, 2008) , fear conditioning and extinction , the anticipation of negative images (Simmons et al, 2008) , the retrieval of emotional or neutral stimuli (Bremner et al, 2003b; Werner et al, 2009; Whalley et al, 2009) , aversive smells and painful stimuli (Geuze et al, 2007; Vermetten et al, 2007) , and the performance of an emotional Stroop task . Insular cortex activation has been found to be positively correlated with measures of symptom severity (Carrion et al, 2008; Hopper et al, 2007; Osuch et al, 2001 ) and post-scan plasma adrenocorticotropic hormone levels (Liberzon et al, 2007a) . Although greater insular activation in PTSD has been confirmed by a recent voxel-wise meta-analysis (Etkin and Wager, 2007) , a few studies have reported either no group differences in insular activation or relatively decreased activation in PTSD (Bremner et al, 1999a (Bremner et al, , 2004 Molina et al, 2007; Moores et al, 2008; Phan et al, 2006a; Shin et al, 1999) .
Voxel-based morphometry studies of PTSD have reported reduced gray matter density in the insular cortex (Chen et al, 2006; Corbo et al, 2005; Kasai et al, 2008) . In one study, gray matter density in the insular cortex was negatively correlated with reexperiencing; that is, lower gray matter density was associated with greater reexperiencing (Kasai et al, 2008) .
One recent PET-[ 11 C]flumazenil study has reported decreased benzodiazepine-GABA A receptor binding in bilateral insular cortex in PTSD (Geuze et al, 2008a) .
Summary. In general, the functional neuroimaging findings in PTSD support the hypothesis that the amygdala is hyperresponsive and ventral portions of medial prefrontal cortex are hyporesponsive, at least in some groups of PTSD patients. Indeed, the latter finding appears to be one of the most robust in the literature (Etkin and Wager, 2007) (Table 1 ). In addition, albeit in a small number of studies, reduced volumes and gray matter densities in the ACC have been fairly consistently reported. Furthermore, emerging evidence suggests that the dACC and insular cortex may be hyperresponsive in PTSD, although insular cortex hyperresponsivity does not appear to be specific to PTSD (Etkin and Wager, 2007) . Finally, the majority of studies have found diminished hippocampal volumes in PTSD patients. Hippocampal function appears to be abnormal as well, although the direction of the abnormality seems to depend on the type of task completed during neuroimaging.
Panic Disorder
Panic disorder patients experience recurrent, unexpected panic attacks, along with a persistent concern about having future attacks, or worry about the implications of the attacks, or a significant change in behavior related to the attacks (APA, 2000) . A panic attack is a discrete episode of intense fear, discomfort, and sympathetic nervous system arousal that occurs in the absence of true danger (APA, 2000) . According to one of the neurocircuitry models of panic disorder, the 'fear network,' which includes the amygdala, hippocampus, thalamus, and brain stem structures, is hypersensitive. Furthermore, frontal cortex fails to provide top-down inhibitory input to the amygdala, leading to exaggerated amygdala activation and unnecessary activation of the entire fear network, resulting in a panic attack (Coplan and Lydiard, 1998; Gorman et al, 2000) . This type of model is similar to the models proposed for other anxiety disorders such as PTSD. Indeed, PTSD patients often suffer from comorbid panic attacks (Falsetti and Resnick, 1997 ). Although it is quite possible that PTSD and panic disorder indeed share similar pathophysiological components, it will be important in the future to identify abnormalities that are disorder specific and are responsible for disorder-specific symptomatology.
Amygdala. Hyperactivation of the amygdala in panic disorder has been reported in response to panic-related words (van den Heuvel et al, 2005b) and neutral faces (Pillay et al, 2007) . One recent PET study found greater resting glucose metabolism in the amygdala (Sakai et al, 2005) , although amygdala glucose metabolism did not change after effective treatment with cognitive-behavioral therapy (Sakai et al, 2006) . The possibility that amygdala hyperactivation is present in a subgroup of panic disorder patients has been supported by recent studies examining the effect of genotypes within patients with panic disorder. These have revealed greater amygdala activation in carriers of the COMT 158val allele (Domschke et al, 2008) , the 5-HT1A x1019 GG allele, and the short allele of the serotonin transporter polymorphism (Domschke et al, 2006) . In contrast, two studies found relatively decreased amygdala activation during anticipatory anxiety (Boshuisen et al, 2002) and in response to fearful facial expressions (Pillay et al, 2006) , although the latter finding may be attributed to the fact that panic disorder patients were taking antidepressants, which have been found to decrease amygdala activation (Harmer et al, 2006) .
The volumetric findings in the amygdala of panic disorder patients are very sparse. One study reported smaller bilateral amygdala volumes in panic disorder compared with healthy participants (Massana et al, 2003) . The same group reported reduced levels of creatine and phosphocreatine in the right medial temporal lobe (including the amygdala and part of the hippocampus) in panic disorder. This was interpreted as potentially representing a hypermetabolic state in the right medial temporal region (Massana et al, 2002) , which would be consistent with the findings of Sakai et al (2005) . Finally, with respect to relevant neurotransmission findings, SPECT and PET studies have reported decreased GABA-benzodiazepine receptor binding in the medial temporal lobes (Kaschka et al, 1995; Malizia et al, 1998 ) and decreased 5-HT1 A receptor binding in the amygdala in panic disorder (Nash et al, 2008) .
Medial prefrontal cortex. Consistent with the literature on pharmacologically induced fear and panic in healthy volunteers, studies of panic disorder have revealed increased rACC activation during imagery of high vs low anxiety situations (Bystritsky et al, 2001) , anticipatory anxiety (Boshuisen et al, 2002) , and in response to happy faces in panic disorder (Pillay et al, 2007) , although medication was a potential confound in the latter study. Dorsal ACC hyperresponsivity has also been reported in panic disorder in one study (Pillay et al, 2007) . Panic disorder patients who are carriers of the COMT 158val allele appear to have less medial prefrontal deactivation and greater orbitofrontal activation in response to emotional facial expressions (Domschke et al, 2008) . In contrast, panic disorder subjects with the 5-HT1A x1019 GG allele had less ACC, medial prefrontal cortex, and orbitofrontal activation in response to fearful facial expressions (Domschke et al, 2006) .
Volumetric evidence is again sparse, but it appears that both dACC and rACC might be exhibiting similar types of change. Gray matter volumes appear to be reduced in the rACC (Asami et al, 2008; Uchida et al, 2008) and dACC (Asami et al, 2008) , and white matter integrity, as measured by DTI, appears to be enhanced in the rACC in panic disorder (Han et al, 2008) .
Two studies have reported decreased GABA A -benzodiazepine receptor binding in the ACC and medial prefrontal cortex, including in the dACC (Hasler et al, 2008; Malizia et al, 1998) , and one study found a negative correlation between panic attack symptom severity and benzodiazepine receptor binding in dorsal medial frontal gyrus (Bremner et al, 2000b ). An MRS study reported increased lactate and choline levels in the rACC (Ham et al, 2007b) , and two PET studies have reported decreased 5-HT1 A receptor binding in the anterior cingulate in panic disorder (Nash et al, 2008; Neumeister et al, 2004) .
Hippocampus. The evidence for hippocampal involvement in panic disorder comes mainly from studies of metabolism and perfusion. Two PET studies of panic disorder have reported abnormalities in the laterality of hippocampal resting glucose metabolic rates (Nordahl et al, 1990 (Nordahl et al, , 1998 , and two PET studies have found greater resting glucose metabolism in the hippocampus in patients with panic disorder (Bisaga et al, 1998; Sakai et al, 2005) . In contrast, a SPECT study has reported reduced perfusion in the hippocampus in panic disorder (De Cristofaro et al, 1993) . Two studies have reported decreased GABA Abenzodiazepine receptor binding in the hippocampus (Bremner et al, 2000b; Malizia et al, 1998) , and one study has reported the opposite finding (Hasler et al, 2008) .
Insular cortex. With regard to the insular cortex in panic disorder, studies have reported decreased activity during anticipatory anxiety (Boshuisen et al, 2002) , increased gray matter volume (Protopopescu et al, 2006; Uchida et al, 2008) , decreased 5-HT1 A receptor binding (Nash et al, 2008) , and decreased GABA A -benzodiazepine receptor binding (Malizia et al, 1998). Brain stem. Functional neuroimaging studies have reported increased glucose metabolic rates (Sakai et al, 2005) and increased activity during anticipatory anxiety (Boshuisen et al, 2002) in the brain stem in panic disorder. Gray matter volume appears to be increased in the midbrain and pons (Protopopescu et al, 2006; Uchida et al, 2008) . Decreased GABA A -benzodiazepine receptor binding was reported in the pons (Malizia et al, 1998) , and two studies have found decreased 5-HT1 A receptor binding in the raphe nucleus in panic disorder (Nash et al, 2008; Neumeister et al, 2004) .
Summary. Several studies have provided evidence consistent with amygdala and brain stem hyperresponsivity in panic disorder. Activation in rACC and dACC appears to be increased, and gray matter volumes in these regions appear to be decreased. Several studies have reported decreased GABA A -benzodiazepine and 5-HT 1A receptor binding in the amygdala, medial prefrontal cortex, insular cortex, and brain stem in panic disorder. A common limitation seen in several neuroimaging studies of this disorder is the inclusion of participants taking psychiatric medications (Domschke et al, 2006 (Domschke et al, , 2008 Han et al, 2008; Pillay et al, 2006 Pillay et al, , 2007 Uchida et al, 2008) . Thus, the findings of such studies should be interpreted cautiously pending replication in medication-free participants.
Social Phobia
Social phobia (or social anxiety disorder) is characterized by a marked and persistent fear of social or performance situations involving possible scrutiny by others (APA, 2000) . The fear of embarrassment and distress can lead to avoidance of social situations and impairment in social, occupational, and academic functioning. The amygdala and medial prefrontal cortex have been considered important regions of interest in this disorder (Amaral, 2002; Liebowitz et al, 2005; Mathew et al, 2001; Stein et al, 2002a; Stein, 1998) .
Amygdala. Exaggerated amygdala responses in social phobia have been observed during public speaking (Tillfors et al, 2001) , the anticipation of public speaking (Lorberbaum et al, 2004; Tillfors et al, 2002) , negative comments (Blair et al, 2008a) , and in response to neutral, angry, contemptuous, happy, and schematic angry facial expressions (Birbaumer et al, 1998; Blair et al, 2008b; Cooney et al, 2006; Evans et al, 2008; Gentili et al, 2008; Guyer et al, 2008; Phan et al, 2006b; Schneider et al, 1999; Stein et al, 2002b; Straube et al, 2004a Straube et al, , 2005 Veit et al, 2002; Yoon et al, 2007) . One study found temporally delayed amygdala responses to faces in a social phobia group compared with a healthy control group . In addition, amygdala responses in social phobia have been positively correlated with self-reported fear increases (Tillfors et al, 2001) , severity of social anxiety symptoms (Blair et al, 2008b; Evans et al, 2008; Guyer et al, 2008; Phan et al, 2006b) , and state-trait anxiety scores (Cooney et al, 2006) . The genetic predisposition for social phobia has been supported by the finding that social phobia patients with a short allele of the serotonin transporter polymorphism had greater amygdala responses during public speaking compared to those with long alleles (Furmark et al, 2004) . Finally, amygdala activation during public speaking in social phobia appears to decrease with successful treatment (Furmark et al, , 2005 . In contrast, one recent study found decreased amygdala activation during script-driven imagery of anxiety-provoking social situations and a mental arithmetic task in social phobia (Kilts et al, 2006) . One study has reported reduced 5-HT 1A receptor binding in the amygdala in this disorder (Lanzenberger et al, 2007) .
Medial prefrontal cortex. Exaggerated rACC activation in social phobia has been found in response to facial expressions of fear (Blair et al, 2008b) and disgust (Amir et al, 2005) , and in response to pictures of peers with whom patients did not want to interact (Guyer et al, 2008) . One study reported greater orbitofrontal cortex activation to angry vs neutral prosody (Quadflieg et al, 2008) . In contrast, other studies have found decreased activation (Van Ameringen et al, 2004) and decreased glucose metabolic rates in the ventromedial prefrontal cortex (Evans et al, 2009) , which increased following treatment with tiagabine (Evans et al, 2009) . Glutamate/creatine and NAA/creatine ratios appear to be elevated in the rACC and are correlated with symptom severity .
Studies of dACC function in social phobia also have been somewhat mixed. Greater dACC activation has been reported in response to negative comments (Blair et al, 2008a) and harsh or disgusted facial expressions (Amir et al, 2005; Phan et al, 2006b) . Another study reported greater dorsal medial frontal activation in response to harsh faces (Stein et al, 2002b) . Treatment with nefazodonedecreased activation in dACC (Kilts et al, 2006) . In contrast, other studies have found decreased dACC activation to schematic angry faces (Evans et al, 2008) and in anticipation of public speaking (Lorberbaum et al, 2004) , as well as decreased glucose metabolism at rest (Evans et al, 2009) . One study found temporally delayed medial prefrontal cortex/dACC responses to faces in social phobia, which may help to account for the heterogeneity of findings in the literature regarding this structure . Finally, one study reported reduced 5-HT 1A receptor binding in the anterior cingulate in social phobia, although whether this finding occurred in the dorsal or rostral ACC was not specified (Lanzenberger et al, 2007) .
Insular cortex. Insular cortex activation appears to be elevated in social phobia during the anticipation of public speaking (Lorberbaum et al, 2004) and in response to emotional facial expressions (Amir et al, 2005; Gentili et al, 2008; Straube et al, 2004a Straube et al, , 2005 Yoon et al, 2007) , including schematic facial expressions (Evans et al, 2008; Straube et al, 2004a) . Two studies, however, found decreased insular cortex activation during public speaking (Tillfors et al, 2001) and during an implicit sequence-learning task in social phobia . One study has found reduced 5-HT 1A receptor binding in the insular cortex in this disorder (Lanzenberger et al, 2007) .
Striatum. One recent study has found reduced caudate activation during an implicit sequence-learning task in generalized social phobia . Other studies have found reduced D 2 receptor binding and dopamine transporter densities in the striatum in social phobia (Schneier et al, 2000; Tiihonen et al, 1997) , although a recent study failed to replicate these findings (Schneier et al, 2009 ).
Summary. Exaggerated amygdala activation has been the most consistent functional neuroimaging finding in the social phobia literature. Although several studies have reported exaggerated rACC and insular cortex activation as well, a number of other studies have reported contradictory findings. Future research will have to: (1) address questions regarding ACC/mPFC and insular involvement, potentially utilizing cognitive activation tasks to probe ACC function, and (2) attempt to identify the neurocircuitry specific to social phobia (eg, the regions that contribute to the perception/interpretation of social stimuli as particularly anxiety/fear inducing).
Specific Phobia
Specific phobias are marked by excessive, unreasonable and persistent fear of specific objects or situations such as small animals, flying, enclosed places, heights, and blood/injury (APA, 2000) . The fear and avoidance causes significant distress and/or impairment in occupational, academic, or social functioning. Specific phobia is a relatively common disorder, with a lifetime prevalence of 7-11% (APA, 2000) . Early models of the etiology of phobias centered on fear conditioning and extinction, and therefore implicated the amygdala and medial prefrontal cortex. Admittedly, such fear conditioning models are likely to be incomplete given that (1) many individuals with phobias cannot recall a conditioning event, and (2) only a small number of common stimuli or situations are the objects of phobias (Fyer, 1998) . Nevertheless, fear conditioning and extinction models have been useful in guiding neuroimaging researchers toward examining amygdala, medial prefrontal cortex, and insular cortex function in this disorder.
Amygdala. Exaggerated amygdala activation in individuals with specific phobia has been observed in response to phobia-related pictures (Dilger et al, 2003; Goossens et al, 2007a, b; Schienle et al, 2005 Schienle et al, , 2007 Straube et al, 2006b; Veltman et al, 2004; Wendt et al, 2008) . In addition, treatment has been associated with decreased amygdala activation (Goossens et al, 2007b; Schienle et al, 2007) . However, numerous studies have not reported exaggerated amygdala activation in specific phobia Larson et al, 2006; Paquette et al, 2003; Straube et al, 2004b Straube et al, , 2007 Wik et al, 1996 Wik et al, , 1997 Wright et al, 2003) , perhaps in part due to methodological differences, such as the use of different imaging modalities, type of stimuli (verbal vs pictorial), mode of presentation (video clips vs stills), or phobia-unrelated facial expressions. Preliminary findings assessing the NK1 receptor have suggested enhanced levels of endogenous neuropeptide substance P (commonly associated with stress and negative affect) in the amygdala in phobics when presented with phobia-relevant pictures (Michelgard et al, 2007) .
Medial prefrontal cortex. The findings with regard to the rACC in specific phobia are mixed, with two studies showing less rACC activation in phobia groups in response to phobia-related vs neutral pictures Schienle et al, 2007) , and two studies reporting enhanced rACC activation to phobia-related stimuli (Britton et al, 2009; Pissiota et al, 2003) . Activation in the rACC appears to be positively correlated with anticipatory anxiety in phobia patients (Straube et al, 2007) . The rACC has been shown to be thicker in participants with specific phobias relative to control participants without phobias (Rauch et al, 2004) .
In contrast, the results of functional neuroimaging studies are much more consistent with regard to the dACC, which has been found to be hyperresponsive to phobia-related stimuli (Goossens et al, 2007a, b; Straube et al, 2006a, b) or the anticipation of such stimuli (Straube et al, 2007) . In addition, dACC activation in specific phobia decreases after habituation and cognitive-behavioral treatment (Goossens et al, 2007b; Straube et al, 2006a) .
Insular cortex. Recent research has reported exaggerated insular cortex activation in specific phobia vs control cohorts in response to phobia-or fear-related pictures, videos, and words (Dilger et al, 2003; Goossens et al, 2007a, b; Schienle et al, 2005; Straube et al, 2004b Straube et al, , 2006b Straube et al, , 2007 Wendt et al, 2008) , as well as fearful facial expressions . In addition, treatment studies have reported decreased insula activation following cognitivebehavioral treatment (Goossens et al, 2007b; Schienle et al, 2007; Straube et al, 2006a) . Insular cortex also appears to be thicker (bilaterally) in participants with specific phobia as compared with healthy control participants (Rauch et al, 2004) .
Summary. The amygdala, dACC and insular cortex all appear to be hyperresponsive to phobia-related stimuli in specific phobia. These abnormalities tend to normalize with successful treatment. The findings are few and mixed with regard to the rACC.
Obsessive-Compulsive Disorder
Patients with obsessive-compulsive disorder (OCD) experience recurrent, unwanted thoughts or images (obsessions) that cause distress, and engage in excessive ritualistic behaviors or mental acts (compulsions) that are typically carried out in response to the obsessions (APA, 2000) . Because OCD is covered more extensively in another chapter, we only very briefly discuss it here (see also Friedlander and Desrocher, 2006; Menzies et al, 2008) . In general, abnormalities in thalamo-cortico-striatal loops have been posited to account for the repetitive quality and the cognitive and motor content of the obsessions and compulsions in OCD. One neurocircuitry model of OCD posits that the striatum (caudate nucleus) functions abnormally, leading to inefficient gating in the thalamus (Graybiel and Rauch, 2000; Rauch et al, 1998a) . This may lead to hyperactivity in the orbitofrontal cortex and the anterior cingulate cortex, which may mediate intrusive thoughts and anxiety, respectively. Compulsions may serve to recruit the striatum and to achieve thalamic gating, thereby neutralizing the obsessions and reducing anxiety. Thus, the fear/anxiety-related brain regions that we have focused on so far (eg, amygdala, mPFC, insula, and hippocampus) do not appear to mediate the core OCD symptomatology. It is interesting to note here that the neurocircuitry model of OCD is much further developed (eg, nodes, links, and directionality are better specified) than the models of other anxiety disorders. There could be a number of factors contributing to this: (1) OCD has been studied longer than other anxiety disorders; (2) The nature of OCD symptoms (for example the predominant cognitive component) implicated neurocircuitry that is better understood or is organized in a way that renders itself easier for the development of circuitry-based models. Whatever the reason might be, one of the goals for future research in other anxiety disorders should be to strive to develop neurocircuitry hypotheses that are comparable in detail and specifications to the models that are already available for OCD.
Although some functional neuroimaging studies have found elevated amygdala activation in OCD (Breiter et al, 1996b; van den Heuvel et al, 2004; Van Laere et al, 2006) , the majority have not, even with facial expression paradigms that are known to activate the amygdala in healthy subjects and patients with other anxiety disorders (Cannistraro et al, 2004) . The preponderance of neuroimaging studies have identified functional and/or structural abnormalities in the components of thalamo-cortico-striatal loops: striatum (Bartha et al, 1998; Baxter et al, 1987 Baxter et al, , 1988 Chen et al, 2004; Rauch et al, 1994 Rauch et al, , 1997 Remijnse et al, 2006; Robinson et al, 1995; Rosenberg et al, 1997; van den Heuvel et al, 2005a) , thalamus (Atmaca et al, 2006; Chen et al, 2004; Fitzgerald et al, 2000; Gilbert et al, 2000) , orbitofrontal cortex (Baxter et al, 1987 (Baxter et al, , 1988 Chamberlain et al, 2008; Chen et al, 2004; Kang et al, 2004; Rauch et al, 1994; Remijnse et al, 2006; Valente et al, 2005) , and the ACC (Ebert et al, 1997; Fitzgerald et al, 2005; Rauch et al, 1994; Valente et al, 2005) . In addition, recent receptor imaging studies in OCD have revealed reduced serotonin transporter availability in the thalamus and midbrain (Reimold et al, 2007) , as well as reduced 5-HT 2A receptor availability in the ACC and other frontal cortical areas (Perani et al, 2008) . One interesting and unanswered question remains: If OCD is indeed associated with very high anxiety states, especially linked to specific worries or compulsions, why doesn't the circuitry associated with other anxiety disorders or state anxiety in healthy controls have a more prominent role in the expression of this anxiety?
Generalized Anxiety Disorder
Generalized anxiety disorder (GAD) is characterized by excessive diffuse anxiety and worry that is difficult to control. Patients with GAD may experience restlessness, fatigue, irritability, muscle tension, and sleep and concentration difficulties (APA, 2000) . Relatively few neuroimaging studies of GAD exist in the literature and some of the findings are conflicting; however, some studies have implicated the amygdala and medial prefrontal cortex in this disorder.
Amygdala. Exaggerated amygdala activation in response to fearful (McClure et al, 2007b) and masked angry facial expressions (Monk et al, 2008) and during the anticipation of aversive photographs (Nitschke et al, 2009) has been reported in patients with GAD. In a mixed cohort of subjects with GAD and social phobia, subjects who had a low tolerance for uncertainty had elevated amygdala activation during a decision-making task (Krain et al, 2008) . In a study of adolescents with GAD, amygdala responses were positively correlated with GAD symptom severity (Monk et al, 2008) . However, other studies have not found exaggerated amygdala activation in GAD (Blair et al, 2008b; Whalen et al, 2008) . In a recent treatment study, greater pre-treatment left amygdala activation to fearful faces was associated with a less favorable response to venlafaxine (Whalen et al, 2008) ; in contrast, a different study on a pediatric GAD sample found that greater pretreatment left amygdala activation to fearful faces was associated with a more favorable response to cognitivebehavioral treatment (McClure et al, 2007a) . One study has reported larger amygdala volumes in pediatric GAD (De Bellis et al, 2000a) .
Medial prefrontal cortex. Although the literature is currently very small, it appears that medial prefrontal cortex activation may be elevated in GAD. Activation in dACC and rACC appears to be elevated in response to fearful facial expressions in adolescents with GAD (McClure et al, 2007b) . In a mixed cohort of subjects with GAD and social phobia, those with higher intolerance for uncertainty had elevated rACC and subgenual ACC activation during a decision-making task (Krain et al, 2008) . In addition, dorsal ACC activation in response to worry vs neutral statements declined significantly after treatment with citalopram (Hoehn-Saric et al, 2004) . Finally, greater pre-treatment rACC activation in response to fearful facial expressions (Whalen et al, 2008) and the anticipation of emotional stimuli (Nitschke et al, 2009 ) was associated with a more favorable response to venlafaxine. Regions in lateral prefrontal cortex also appear to show exaggerated activation (Monk et al, 2006) and elevated NAA/creatine ratios in GAD (Mathew et al, 2004 ).
Summary. Although there is some evidence for exaggerated amygdala and medial prefrontal cortex responses in GAD, there are too few studies to form conclusions about the role of these structures in the pathophysiology of GAD. Future functional neuroimaging studies using fearful facial expressions and tasks that probe medial prefrontal cortex function (eg, extinction, emotion regulation, or interference tasks) might be able to contribute the much needed additional information regarding amygdala and medial prefrontal cortex function in GAD.
Summary
Overall, the findings of functional neuroimaging studies are consistent with the notion of exaggerated amygdala activation to specific stimuli in a number of anxiety disorders, especially social phobia, specific phobia, and PTSD. Facial expressions have been especially effective probes of amygdala responses in social phobia and PTSD. Interestingly, the data regarding amygdala function in panic disorder are still inconclusive, and given that relatively few studies have examined amygdala function in GAD, additional research is needed to make meaningful comparisons of amygdala responses between various anxiety disorders. Although increased amygdala activation has been observed in a few studies of OCD, the overall pathophysiology of OCD appears to be localized to a different brain circuit.
One potential conceptualization of these findings is that amygdala hyperactivation is a common pathway for exaggerated anxiety/fear that is triggered by specific stimuli. Thus anxiety disorders that manifest increased fear/anxiety that is associated with specific identifiable stimuli (eg, PTSD, social phobia, and specific phobia) will have evidence of exaggerated amygdala reactivity. Panic attacks, on the other hand, can occur in the absence of such stimuli and might thus involve activation of other structures within fear/anxiety neurocircuitry (such as brain stem nuclei, periaqueductal gray, and mPFC). If this is the case, it can explain why the degree of amygdala activation in panic disorder may vary depending on the presence of identified panic-related stimuli and/or other brain regions activated. Conceptually, the hyperresponsivity of amygdala and brain stem is consistent with cognitive and somatic manifestation of panic attacks; however, hyperactivation of the anterior cingulate is probably more consistent with compensatory/ regulatory roles rather than reflecting panic-specific pathophysiology. Consistent with the findings of the meta-analysis of Etkin and Wager (2007) , relatively diminished rACC activation has been reported fairly consistently in PTSD, but not in other anxiety disorders. Thus, relatively diminished rACC function may be specific to PTSD and could reflect abnormalities in recall/contextualization of fear memories. Activation in other regions like the dACC and insular cortex appears to be elevated in PTSD and in several of the other anxiety disorders. Exaggerated activation in these regions may reflect various aspects of anxiety/fear response, such as anticipatory anxiety, interoceptive components, autobiographic memory, or anxiety proneness Shin et al, in press; Simmons et al, 2006) . Together these findings can be conceptualized as an evidence of hyperresponsive threat detection, autobiographic memory, and somatic/physiological reactivity systems in PTSD, accompanied by the failure in regulatory regions responsible for safety signaling, fear extinction, and stimulus appraisal, together leading to aberrant contextual processing of the threat-related stimuli.
The hippocampus was studied most frequently in PTSD and panic disorder, but rarely in the other disorders. Thus, whether similar structural and functional abnormalities in the hippocampus occur in other anxiety disorders is uncertain. Although the evidence for hippocampal involvement in memory and contextual processing is strongly supported by animal studies, and deficits in hippocampal function (eg, contextual processing) are consistent with the PTSD model outlined above, more information is needed to understand the role of the hippocampus in anxiety disorders.
However, neuroimaging studies of anxiety disorders are not without limitations. On the technical side, the spatial resolution of functional neuroimaging techniques is limited, and even those techniques with the best spatial resolution (fMRI) cannot accurately differentiate between very small adjacent structures (such as subnuclei of the amygdala). This, in addition to the presence of susceptibility artifacts (in the case of fMRI studies), makes resolution of potentially important structures, such as the hypothalamus and brain stem nuclei, particularly problematic for studies of fear/anxiety neurocircuitry. In addition, the temporal resolution of some of the imaging techniques used (ie, PET and SPECT) makes it difficult to detect quick and transient responses to stimuli. On the clinical side, the use of medications (ie, antidepressants or benzodiazepines) in patient groups can affect brain activation and represent a confounding factor. However, for regions such as the amygdala, medications tend to normalize amygdala responses rather than exaggerate them (Harmer et al, 2006; Paulus et al, 2005) . Comorbidity represents a challenge as well. The majority of patients with anxiety disorders have comorbid conditions, such as depression. Although it is tempting to exclude from neuroimaging studies those anxiety disorder patients with comorbid conditions, this procedure raises concerns about the ability to generalize findings to the larger population of individuals with anxiety disorders. Recent studies have attempted to deal with this issue by separating anxiety disorder patients into groups with and without comorbidity Lanius et al, 2007) .
FUTURE RESEARCH DIRECTIONS
Although much information that is relevant to the pathophysiology of anxiety disorders has been gained over the last two decades, many research questions remain to be answered. As we have noted previously, questions remain regarding the specific roles of the amygdala, medial prefrontal cortex, insula, and hippocampus in the anxiety disorders. In addition, one of the more general and basic questions is whether the functional abnormalities identified in anxiety disorders represent acquired signs of the disorders or vulnerability factors that increase the risk of developing the disorders. For example, does amygdala hyperresponsivity occur after the symptoms of social phobia, specific phobia, or PTSD appear? Or does the amygdala hyperresponsivity precede the development of symptoms and increase the risk for developing them? Two types of studies could be used to try to address these questions. First, longitudinal studies that include functional neuroimaging could assess functional activation before the onset of anxiety symptoms (or before trauma exposure in the case of PTSD) to determine whether baseline amygdala activation predicts (or increases the risk for) subsequent anxiety disorder diagnoses. One recent study using a variant of this longitudinal design has yielded findings suggesting that amygdala activation may represent a vulnerability factor. In this study, amygdala activation in response to novel faces was studied in adults who were categorized in childhood as either behaviorally inhibited or uninhibited (Schwartz et al, 2003) . Behavioral inhibition in childhood is a known risk factor for the development of social anxiety later in life (Biederman et al, 2001; Schwartz et al, 1999) . Amygdala activation was greater in the inhibited group as compared with the uninhibited group, and this finding remained even when inhibited subjects with social phobia were removed from the analyses. Although this study does not provide definitive proof that exaggerated amygdala activation is a vulnerability factor for the development of social phobia, it does lend some support to the idea.
The second type of study that can help determine whether functional abnormalities are acquired characteristics or vulnerability factors involves studying the identical twins of probands with vs without the disorder in question. With regard to PTSD, Roger Pitman and colleagues have studied combat veterans with PTSD and their combat-unexposed identical co-twins without PTSD, as well as combat veterans who never had PTSD and their identical combat-unexposed co-twins without PTSD. Structural and functional abnormalities that are observed in both the individuals with PTSD and their identical trauma-unexposed co-twins likely represent familial vulnerability factors, whereas abnormalities that are observed only in the individuals with PTSD would be consistent with acquired characteristics. Using this type of design, diminished hippocampal volumes (Gilbertson et al, 2002) and dACC hypermetabolism (Shin et al, in press) appear to be familial vulnerability factors, whereas diminished gray matter volumes in the rACC appear to be acquired characteristics (Kasai et al, 2008) .
This twin design, however, is unable to determine whether familial vulnerability is attributable to genetic vs environmental factors. Future studies will be needed to determine whether the functional abnormalities that appear to be familial vulnerability factors are associated with specific genotypes. For example, dACC hypermetabolism has been reported in healthy carriers of the short allele of the serotonin transporter polymorphism (Graff-Guerrero et al, 2005) . The prevalence of the short allele appears to be elevated in PTSD (Lee et al, 2005) , and the finding of dACC hypermetabolism in individuals with PTSD and their identical co-twins could be at least in part attributable to the presence of this short allele. Future studies will evaluate this possibility. Studies that examine links between specific genotypes and endophenotypes (eg, neuroimaging or neuroendocrine measures) that may predispose individuals to various anxiety disorders following environmental modulation (during development or in adulthood) are likely to prove very valuable in future research.
Much more progress is urgently needed in examining in vivo neurochemistry in anxiety disorders. SPECT, PET, and MRS studies are needed to link functional neuroimaging data with cellular and molecular changes that might be driving these abnormalities. Finally, another major future direction would entail using functional neuroimaging to predict treatment response in patients with anxiety disorders. This type of research has recently begun, and some studies have reported that greater amygdala activation at a pre-treatment baseline predicts a less favorable response to (1) cognitive-behavioral therapy in PTSD (Bryant et al, 2008a) , and (2) venlafaxine in GAD (Whalen et al, 2008) . Future studies will be needed to determine whether specific pre-treatment functional neuroimaging profiles can distinguish between those who will respond to medication vs cognitive-behavioral treatments. One ultimate goal of this research would be to determine whether functional neuroimaging measures can be used to guide treatment choice for individual patients.
